MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s15010-024-02445-0

Медицинская библиотека · Infection · 2024

Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study.

Attias Nofar Hezkelo, Schlaeffer-Yosef Tal, Zahavi Itay, Hasson Noga, Ari Yaara Ben, Darawsha Basel, Levitan Idan, Goldberg Elad, Landes Michal, Litchevsky Vladislav, Ben-Zvi Haim, Amit Sharon, Nesher Lior, Bishara Jihad, Paul Mical, Yahav Dafna, Margalit Ili

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

PURPOSE: The prolonged treatment recommended for nocardiosis does not rely on strong evidence. Consequently, some clinicians opt shorter therapy in certain circumstances. We assessed the effectiveness of shorter therapy.

METHODS

A multi-center retrospective cohort study comprising individuals diagnosed with nocardiosis between 2007 and 2022. We classified all patients who survived 90 days into three groups according to treatment duration: short (≤ 90 days), intermediate (91-180 days), and prolonged (> 180 days). We compared baseline characteristics (comorbidities, immune status) and nocardiosis manifestations across the unadjusted treatment groups, one-year all-cause mortality, disease relapse, and antibiotic-related adverse events to identify patients who may safely receive the short course.

RESULTS

We detected 176 patients with nocardiosis, their median age was 65 years; 74 (42%) were women. Forty-three (24%) patients died within 90 days. Of the remaining 133, 37 (28%) patients received short therapy, 40 (30%) intermediate, and 56 (42%) prolonged treatment duration. Longer courses were more likely to be administered to patients with immunosuppression, disseminated nocardiosis, and N. farcinica infection. Within a year, 20 (15%) individuals died and 2 (2%) relapsed. Treatment duration was not associated with either mortality (p = 0.945) or relapse (p = 0.509). Nocardiosis was the cause of death in only one patient, receiving a prolonged course. Of 73 patients with solitary pulmonary nocardiosis, 20 (27%) received short duration. None relapsed and 2 (10%) died, both immunocompromised. The rate of AE was similar across the groups.

CONCLUSIONS

With clinically guided case-by-case patient selection nocardiosis can be safely treated for durations significantly shorter than traditionally recommended.

Для цитирования: Attias Nofar Hezkelo, Schlaeffer-Yosef Tal, Zahavi Itay, Hasson Noga, Ari Yaara Ben, Darawsha Basel, Levitan Idan, Goldberg Elad, Landes Michal, Litchevsky Vladislav, Ben-Zvi Haim, Amit Sharon, Nesher Lior, Bishara Jihad, Paul Mical, Yahav Dafna, Margalit Ili. Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study.. Infection. 2024. DOI: 10.1007/s15010-024-02445-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.